 LONDON and RALEIGH, N.C., Oct. 26, 2022 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma or the Company, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the third quarter ended September 30, 2022 on Wednesday, November 9, 2022 and host an investment community conference call at 9:00 a.m. EST 2:00 p.m. GMT to discuss these financial results and provide a corporate update. 